Tested Applications
| Positive WB detected in | mouse brain tissue, rat brain tissue |
| Positive IHC detected in | human prostate cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:8000 |
| Immunohistochemistry (IHC) | IHC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
55158-1-AP targets IDUA in WB, IHC, IP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | iduronidase, alpha-L- |
| Calculated Molecular Weight | 73 kDa |
| Observed Molecular Weight | 73 kDa |
| GenBank Accession Number | NM_000203 |
| Gene Symbol | IDUA |
| Gene ID (NCBI) | 3425 |
| RRID | AB_11182946 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P35475 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
IDUA belongs to the glycosyl hydrolase 39 family. It hydrolysis of unsulfated alpha-L-iduronosidic linkages in dermatan sulfate. Defects in IDUA are the cause of mucopolysaccharidosis type 1H (MPS1H)( also known as Hurler syndrome), MPS1H/S(also known as Hurler-Scheie syndrome) and MPS1S(also known as Scheie syndrome), which are rare lysosomal storage diseases. This antibody is specific to IDUA.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for IDUA antibody 55158-1-AP | Download protocol |
| WB protocol for IDUA antibody 55158-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
IDUA Polyclonal antibody (55158-1-AP) has a total of 5 citations, published in the journals Molecular Therapy, Frontiers in Immunology, Molecular Therapy – Methods & Clinical Development, Molecular and Cellular Biochemistry, and Human Gene Therapy. The associated research fields include gene therapy (liver-directed and mRNA-LNP strategies correcting mucopolysaccharidosis type I-Hurler), cancer research (prognosis and immunotherapy response in renal clear cell carcinoma), and bone biology (a molecular study on bone mineral density). Cited applications include WB, IHC, IP, and ELISA, in human and mouse species.
| Species | Application | Title |
|---|---|---|
Mol Ther Comparative evaluation of liver-directed knockin strategies with viral and nonviral vectors in mouse inherited disease models. | ||
Front Immunol Leveraging diverse cell-death related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma | ||
Mol Ther Methods Clin Dev Liver-directed gene therapy corrects neurologic disease in a murine model of mucopolysaccharidosis type I-Hurler. | ||
Mol Cell Biochem Why SNP rs3755955 is associated with human bone mineral density? A molecular and cellular study in bone cells. | ||
Hum Gene Ther Lipid Nanoparticle-Delivered mRNA Therapy Corrects Neonatal Murine MPS I-H. |







